Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Chad Morley

Urology Morgantown, WV Medical Doctor

NPI 1033485347 CMS profile 1384347

1 Medical Center Dr, Morgantown, WV 26506

Open in the dashboard

General payments

$5,601

140 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Chad Morley of Morgantown, WV is reported in the CMS Open Payments database as having received $5,601 across 140 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $545 19
2024 General $448 17
2023 General $2,750 20
2022 General $680 25
2021 General $434 21
2020 General $226 15
2019 General $520 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chad Morley
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Chad Morley were reported at $545. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Chad Morley Urology median Middle half National median
2019 $520 $480 $147–$1,201 $163
2020 $226 $246 $87–$645 $114
2021 $434 $358 $111–$1,000 $132
2022 $680 $476 $143–$1,263 $149
2023 $2,750 $560 $168–$1,461 $160
2024 $448 $563 $170–$1,464 $164
2025 $545 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $4,433 107 payments
  2. Medtronic, Inc. $368 15 payments
  3. Olympus America Inc. $217 3 payments
  4. Coloplast Corp $94 2 payments
  5. Medtronic USA, Inc. $83 5 payments
  6. Ethicon US, LLC $73 1 payment
  7. Stryker Corporation $71 1 payment
  8. CooperSurgical, Inc. $68 1 payment
  9. Janssen Scientific Affairs, LLC $63 1 payment
  10. Rochester Medical Corporation $61 1 payment
  11. Other $70 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,566 138 payments
  2. Consulting Fee $2,000 1 payment
  3. Education $35 1 payment
Products named General payments · program years 2019–2025
  1. LithoVue LithoVue_URO $849 24 payments
  2. INTERSTIM $354 14 payments
  3. LITHOVUE Scope $340 16 payments
  4. iTIND System $217 3 payments
  5. LithoVue Elite $198 3 payments
  6. REZUM Pain Management $122 3 payments
  7. LITHOVUE Pain Management $122 7 payments
  8. AMS 800 Artificial Urinary Sphincter $117 1 payment
  9. REZUM Prostate Health $107 3 payments
  10. AMS $98 1 payment
  11. Other $1,025 63 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

140 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record